Global Bio-based Hemostatic Materials Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
154
Industry
Medical Devices
Regions
Global
Updated
April 2026

Report Overview


Report Overview
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Bio-based Hemostatic Materials competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.The price of bio-based hemostatic materials is typically US$20-70 per piece, with an output of approximately 65 million pieces.Bio-based hemostatic materials are functional medical materials derived primarily from natural biological resources, such as chitosan, gelatin, cellulose, and alginates. They possess excellent biocompatibility and biodegradability, and can rapidly stop bleeding by promoting platelet adhesion and aggregation, accelerating the coagulation cascade, or forming a physical barrier. Compared with chemically synthesized alternatives, they reduce potential side effects on the human body while supporting sustainable development. These materials are widely applied in wound care, surgical operations, and emergency medicine.

The global Bio-based Hemostatic Materials market size was estimated at USD 3257.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.60% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Bio-based Hemostatic Materials market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Bio-based Hemostatic Materials market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Bio-based Hemostatic Materials market.
Global Bio-based Hemostatic Materials Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Johnson & Johnson
Medtronic
Baxter
BioCer Entwicklungs-GmbH
BD
Hemostasis
MedTrade Products
Lanhine Medical
Haiyuan Hairun
Yancheng Yankang Medical Equipment
Success Bio-Tech
Beijing Aitekang Medical Technology
Curasan
Regenity

Market Segmentation (by Type)
Hemostatic Powder
Hemostatic Gauze

Market Segmentation (by Application)
Surgery
First Aid

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Bio-based Hemostatic Materials Market
Overview of the regional outlook of the Bio-based Hemostatic Materials Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bio-based Hemostatic Materials Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Bio-based Hemostatic Materials, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Bio-based Hemostatic Materials
    • 1.2 Key Market Segments
      • 1.2.1 Bio-based Hemostatic Materials Segment by Type
      • 1.2.2 Bio-based Hemostatic Materials Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Bio-based Hemostatic Materials Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Bio-based Hemostatic Materials Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Bio-based Hemostatic Materials Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Bio-based Hemostatic Materials Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Bio-based Hemostatic Materials Product Life Cycle
    • 3.3 Global Bio-based Hemostatic Materials Sales by Manufacturers (2020-2025)
    • 3.4 Global Bio-based Hemostatic Materials Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Bio-based Hemostatic Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Bio-based Hemostatic Materials Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Bio-based Hemostatic Materials Market Competitive Situation and Trends
      • 3.8.1 Bio-based Hemostatic Materials Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Bio-based Hemostatic Materials Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Bio-based Hemostatic Materials Industry Chain Analysis
    • 4.1 Bio-based Hemostatic Materials Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Bio-based Hemostatic Materials Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Bio-based Hemostatic Materials Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Bio-based Hemostatic Materials Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Bio-based Hemostatic Materials Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Bio-based Hemostatic Materials Sales Market Share by Type (2020-2025)
    • 6.3 Global Bio-based Hemostatic Materials Market Size by Type (2020-2025)
    • 6.4 Global Bio-based Hemostatic Materials Price by Type (2020-2025)
  • 7 Bio-based Hemostatic Materials Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Bio-based Hemostatic Materials Market Sales by Application (2020-2025)
    • 7.3 Global Bio-based Hemostatic Materials Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Bio-based Hemostatic Materials Sales Growth Rate by Application (2020-2025)
  • 8 Bio-based Hemostatic Materials Market Sales by Region
    • 8.1 Global Bio-based Hemostatic Materials Sales by Region
      • 8.1.1 Global Bio-based Hemostatic Materials Sales by Region
      • 8.1.2 Global Bio-based Hemostatic Materials Sales Market Share by Region
    • 8.2 Global Bio-based Hemostatic Materials Market Size by Region
      • 8.2.1 Global Bio-based Hemostatic Materials Market Size by Region
      • 8.2.2 Global Bio-based Hemostatic Materials Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Bio-based Hemostatic Materials Sales by Country
      • 8.3.2 North America Bio-based Hemostatic Materials Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Bio-based Hemostatic Materials Sales by Country
      • 8.4.2 Europe Bio-based Hemostatic Materials Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Bio-based Hemostatic Materials Sales by Region
      • 8.5.2 Asia Pacific Bio-based Hemostatic Materials Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Bio-based Hemostatic Materials Sales by Country
      • 8.6.2 South America Bio-based Hemostatic Materials Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Bio-based Hemostatic Materials Sales by Region
      • 8.7.2 Middle East and Africa Bio-based Hemostatic Materials Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Bio-based Hemostatic Materials Market Production by Region
    • 9.1 Global Production of Bio-based Hemostatic Materials by Region(2020-2025)
    • 9.2 Global Bio-based Hemostatic Materials Revenue Market Share by Region (2020-2025)
    • 9.3 Global Bio-based Hemostatic Materials Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Bio-based Hemostatic Materials Production
      • 9.4.1 North America Bio-based Hemostatic Materials Production Growth Rate (2020-2025)
      • 9.4.2 North America Bio-based Hemostatic Materials Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Bio-based Hemostatic Materials Production
      • 9.5.1 Europe Bio-based Hemostatic Materials Production Growth Rate (2020-2025)
      • 9.5.2 Europe Bio-based Hemostatic Materials Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Bio-based Hemostatic Materials Production (2020-2025)
      • 9.6.1 Japan Bio-based Hemostatic Materials Production Growth Rate (2020-2025)
      • 9.6.2 Japan Bio-based Hemostatic Materials Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Bio-based Hemostatic Materials Production (2020-2025)
      • 9.7.1 China Bio-based Hemostatic Materials Production Growth Rate (2020-2025)
      • 9.7.2 China Bio-based Hemostatic Materials Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Johnson and Johnson
      • 10.1.1 Johnson and Johnson Basic Information
      • 10.1.2 Johnson and Johnson Bio-based Hemostatic Materials Product Overview
      • 10.1.3 Johnson and Johnson Bio-based Hemostatic Materials Product Market Performance
      • 10.1.4 Johnson and Johnson Business Overview
      • 10.1.5 Johnson and Johnson SWOT Analysis
      • 10.1.6 Johnson and Johnson Recent Developments
    • 10.2 Medtronic
      • 10.2.1 Medtronic Basic Information
      • 10.2.2 Medtronic Bio-based Hemostatic Materials Product Overview
      • 10.2.3 Medtronic Bio-based Hemostatic Materials Product Market Performance
      • 10.2.4 Medtronic Business Overview
      • 10.2.5 Medtronic SWOT Analysis
      • 10.2.6 Medtronic Recent Developments
    • 10.3 Baxter
      • 10.3.1 Baxter Basic Information
      • 10.3.2 Baxter Bio-based Hemostatic Materials Product Overview
      • 10.3.3 Baxter Bio-based Hemostatic Materials Product Market Performance
      • 10.3.4 Baxter Business Overview
      • 10.3.5 Baxter SWOT Analysis
      • 10.3.6 Baxter Recent Developments
    • 10.4 BioCer Entwicklungs-GmbH
      • 10.4.1 BioCer Entwicklungs-GmbH Basic Information
      • 10.4.2 BioCer Entwicklungs-GmbH Bio-based Hemostatic Materials Product Overview
      • 10.4.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Materials Product Market Performance
      • 10.4.4 BioCer Entwicklungs-GmbH Business Overview
      • 10.4.5 BioCer Entwicklungs-GmbH Recent Developments
    • 10.5 BD
      • 10.5.1 BD Basic Information
      • 10.5.2 BD Bio-based Hemostatic Materials Product Overview
      • 10.5.3 BD Bio-based Hemostatic Materials Product Market Performance
      • 10.5.4 BD Business Overview
      • 10.5.5 BD Recent Developments
    • 10.6 Hemostasis
      • 10.6.1 Hemostasis Basic Information
      • 10.6.2 Hemostasis Bio-based Hemostatic Materials Product Overview
      • 10.6.3 Hemostasis Bio-based Hemostatic Materials Product Market Performance
      • 10.6.4 Hemostasis Business Overview
      • 10.6.5 Hemostasis Recent Developments
    • 10.7 MedTrade Products
      • 10.7.1 MedTrade Products Basic Information
      • 10.7.2 MedTrade Products Bio-based Hemostatic Materials Product Overview
      • 10.7.3 MedTrade Products Bio-based Hemostatic Materials Product Market Performance
      • 10.7.4 MedTrade Products Business Overview
      • 10.7.5 MedTrade Products Recent Developments
    • 10.8 Lanhine Medical
      • 10.8.1 Lanhine Medical Basic Information
      • 10.8.2 Lanhine Medical Bio-based Hemostatic Materials Product Overview
      • 10.8.3 Lanhine Medical Bio-based Hemostatic Materials Product Market Performance
      • 10.8.4 Lanhine Medical Business Overview
      • 10.8.5 Lanhine Medical Recent Developments
    • 10.9 Haiyuan Hairun
      • 10.9.1 Haiyuan Hairun Basic Information
      • 10.9.2 Haiyuan Hairun Bio-based Hemostatic Materials Product Overview
      • 10.9.3 Haiyuan Hairun Bio-based Hemostatic Materials Product Market Performance
      • 10.9.4 Haiyuan Hairun Business Overview
      • 10.9.5 Haiyuan Hairun Recent Developments
    • 10.10 Yancheng Yankang Medical Equipment
      • 10.10.1 Yancheng Yankang Medical Equipment Basic Information
      • 10.10.2 Yancheng Yankang Medical Equipment Bio-based Hemostatic Materials Product Overview
      • 10.10.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Materials Product Market Performance
      • 10.10.4 Yancheng Yankang Medical Equipment Business Overview
      • 10.10.5 Yancheng Yankang Medical Equipment Recent Developments
    • 10.11 Success Bio-Tech
      • 10.11.1 Success Bio-Tech Basic Information
      • 10.11.2 Success Bio-Tech Bio-based Hemostatic Materials Product Overview
      • 10.11.3 Success Bio-Tech Bio-based Hemostatic Materials Product Market Performance
      • 10.11.4 Success Bio-Tech Business Overview
      • 10.11.5 Success Bio-Tech Recent Developments
    • 10.12 Beijing Aitekang Medical Technology
      • 10.12.1 Beijing Aitekang Medical Technology Basic Information
      • 10.12.2 Beijing Aitekang Medical Technology Bio-based Hemostatic Materials Product Overview
      • 10.12.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Materials Product Market Performance
      • 10.12.4 Beijing Aitekang Medical Technology Business Overview
      • 10.12.5 Beijing Aitekang Medical Technology Recent Developments
    • 10.13 Curasan
      • 10.13.1 Curasan Basic Information
      • 10.13.2 Curasan Bio-based Hemostatic Materials Product Overview
      • 10.13.3 Curasan Bio-based Hemostatic Materials Product Market Performance
      • 10.13.4 Curasan Business Overview
      • 10.13.5 Curasan Recent Developments
    • 10.14 Regenity
      • 10.14.1 Regenity Basic Information
      • 10.14.2 Regenity Bio-based Hemostatic Materials Product Overview
      • 10.14.3 Regenity Bio-based Hemostatic Materials Product Market Performance
      • 10.14.4 Regenity Business Overview
      • 10.14.5 Regenity Recent Developments
  • 11 Bio-based Hemostatic Materials Market Forecast by Region
    • 11.1 Global Bio-based Hemostatic Materials Market Size Forecast
    • 11.2 Global Bio-based Hemostatic Materials Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Bio-based Hemostatic Materials Market Size Forecast by Country
      • 11.2.3 Asia Pacific Bio-based Hemostatic Materials Market Size Forecast by Region
      • 11.2.4 South America Bio-based Hemostatic Materials Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Bio-based Hemostatic Materials by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Bio-based Hemostatic Materials Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Bio-based Hemostatic Materials by Type (2026-2035)
      • 12.1.2 Global Bio-based Hemostatic Materials Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Bio-based Hemostatic Materials by Type (2026-2035)
    • 12.2 Global Bio-based Hemostatic Materials Market Forecast by Application (2026-2035)
      • 12.2.1 Global Bio-based Hemostatic Materials Sales (K Units) Forecast by Application
      • 12.2.2 Global Bio-based Hemostatic Materials Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.